Recently, we and others have shown that COX-2 selective inhibitor (NS-398) inhibits proliferation of head and neck squamous cell carcinoma (SCC) cell lines expressing COX-2 mRNA (Higashi et al, 2000; Sumitani et al, 2001). The gene discussed is PTGS2; the disease is head and neck squamous cell carcinoma.